PMID- 37941733 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231110 IS - 2364-3722 (Print) IS - 2196-9736 (Electronic) IS - 2196-9736 (Linking) VI - 11 IP - 8 DP - 2023 Aug TI - Settings of a novel electrosurgical generator to enable efficient and safe submucosal endoscopic procedures. PG - E743-E751 LID - 10.1055/a-2085-3757 [doi] AB - Background and study aims A novel electrosurgical generator unit (ESU), ConMed Beamer, was recently introduced to facilitate endoscopic submucosal dissection (ESD) by employing Automatic Cutting Effect (ACE) technology. Its use in submucosal endoscopy has yet to be investigated. The aim of this study was to evaluate the feasibility and safety of performing ESD and peroral endoscopic myotomy (POEM) using novel settings generated with ConMed Beamer ESU. Patients and methods This was a single-center prospective study of 59 consecutive patients undergoing ESD/POEM at a tertiary referral center. ESU settings were initially generated by testing in live animal models prior to first in-human study. The primary outcome was technical success. Secondary outcomes were procedure times, rate of en bloc/R0 resection, and rate of adverse events (AEs). Results A total of 44 patients (50 polyps) and 15 patients underwent ESD and POEM, respectively. En bloc resection, R0 resection, and curative resection rates were 90%, 77.1%, and 70.8%, respectively. Mean maximal length of the lesion was 3.07 cm +/- 1.43 with an average dissection speed of 14.2 cm (2) /hr +/- 11.1. Technical success was achieved in 100% of POEM patients. Mean time (minutes) to complete the POEM procedure was 50.1 min +/- 12.4. Two major AEs occurred among all patients (3.4%). All intraprocedural bleeding events were controlled using the ConMed Beamer ESU. Conclusions ConMed Beamer ESU settings generated from this study were proven safe and effective in a prospective cohort of patients who underwent submucosal endoscopic procedures. This novel ESU can be added to the armamentarium of ESD capable generators. CI - The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). FAU - Jawaid, Salmaan AU - Jawaid S AD - Gastroenterology, Baylor College of Medicine, Houston, United States. RINGGOLD: 3989 FAU - Keihanian, Tara AU - Keihanian T AD - Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, United States. RINGGOLD: 3989 FAU - Khalaf, Mai AU - Khalaf M AD - Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, United States. RINGGOLD: 3989 FAU - Riojas-Barrett, Margarita AU - Riojas-Barrett M AD - Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, United States. RINGGOLD: 3989 FAU - Abdeljaber, Wesam AU - Abdeljaber W AD - Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, United States. RINGGOLD: 3989 FAU - Mercado, Michael AU - Mercado M AUID- ORCID: 0000-0002-6633-0235 AD - Gastroenterology, Baylor College of Medicine, Houston, United States. RINGGOLD: 3989 FAU - Zabad, Noor AU - Zabad N AUID- ORCID: 0000-0002-2102-0524 AD - Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, United States. RINGGOLD: 3989 FAU - Othman, Mohamed O AU - Othman MO AUID- ORCID: 0000-0002-5888-4334 AD - Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, United States. RINGGOLD: 3989 LA - eng PT - Journal Article DEP - 20230816 PL - Germany TA - Endosc Int Open JT - Endoscopy international open JID - 101639919 PMC - PMC10629488 COIS- Conflict of Interest Mohamed O. Othman: Mohamed O Othman is a consultant for Olympus, Boston Scientific Corporation, Abbvie, ConMed, Creo Medical, Lumendi, Nestle and Apollo. Mohamed O Othman received research grants from Lucid Diagnostics, AbbVie, ConMed, Olympus and Boston Scientific. Salmaan Jawaid: Salmaan Jawaid is a consultant for ConMed, Creo Medical, and Lumendi. Tara Keihanian: Tara Keihanian is a consultant for Lumendi and Neptune medical. Mai Khalaf, Margarita Riojas-Barrett, Wesam Abdeljaber, Michael Mercado & Noor Zabad have no conflicts of interest. This study was investigator-initiated study funded by ConMed. The funding body was not involved with the study design, execution or results. The funding body did not contribute to the drafting of this manuscript. EDAT- 2023/11/09 06:42 MHDA- 2023/11/09 06:43 PMCR- 2023/08/01 CRDT- 2023/11/09 04:11 PHST- 2023/01/23 00:00 [received] PHST- 2023/04/18 00:00 [accepted] PHST- 2023/11/09 06:43 [medline] PHST- 2023/11/09 06:42 [pubmed] PHST- 2023/11/09 04:11 [entrez] PHST- 2023/08/01 00:00 [pmc-release] AID - EIO-2023-01-2927-OA [pii] AID - 10.1055/a-2085-3757 [doi] PST - epublish SO - Endosc Int Open. 2023 Aug 16;11(8):E743-E751. doi: 10.1055/a-2085-3757. eCollection 2023 Aug.